Effects of Radiotherapy on Rhabdomyosarcoma and Bone Growth
Author Information
Author(s): Jason A. Horton, Judith A. Strauss, Matthew J. Allen, Timothy A. Damron
Primary Institution: SUNY Upstate Medical University
Hypothesis
Intramuscular implantation of human rhabdomyosarcoma tumor cells will result in more robust tumor growth compared to subcutaneous implantation.
Conclusion
High-dose radiotherapy significantly reduced tumor growth and prolonged survival in tumor-bearing mice, but also caused limb length asymmetry.
Supporting Evidence
- High-dose radiotherapy (10 Gy) significantly prolonged median survival of tumor-bearing mice.
- Radiotherapy resulted in a significant shortening of the irradiated limb by 3.3%.
- A lower dose of radiotherapy (2 Gy) did not extend survival but caused a 4.1% decrease in limb length.
Takeaway
When kids with rhabdomyosarcoma get radiation treatment, it can help fight the cancer but might also make their bones grow unevenly.
Methodology
The study used bioluminescent human rhabdomyosarcoma cell lines to create xenograft tumors in mice, followed by radiotherapy and evaluation of tumor growth and limb length.
Potential Biases
Potential bias due to the use of a single animal model and the lack of diverse experimental conditions.
Limitations
The model does not replicate clinical fractionated radiotherapy protocols and uses immunocompromised mice, which may not be immunologically relevant.
Participant Demographics
NCr nude mice, 21 days old, male.
Statistical Information
P-Value
0.0224
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website